Kristina Andrijauskaite, Rafael J Veraza, Riley P Lopez, Zach Maxwell, Isabella Cano, Exal E Cisneros, Israel J Jessop, Maria Basurto, George Lamberson, Michelle D Watt, Joseph Nespral, Masahiro Ono, Leonid Bunegin
INTRODUCTION: Heart transplant remains the gold standard treatment for patients with advanced heart failure. However, the list of patients waiting for a heart transplant continues to increase. We have developed a portable hypothermic oxygenated machine perfusion device, the VP.S ENCORE®, to extend the allowable preservation time. The purpose of this study was to test the efficacy of the VP.S. ENCORE® using deceased donors derived hearts. METHODS: Hearts from brain-dead donors not utilized for transplant ( n = 11) were offered for research from the Texas Organ Sharing Alliance (TOSA), South and Central Texas' Organ Procurement Organization (OPO) and were preserved in the VP...
2024: Frontiers in Cardiovascular Medicine